1. Home
  2. MLAB vs DXYZ Comparison

MLAB vs DXYZ Comparison

Compare MLAB & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • DXYZ
  • Stock Information
  • Founded
  • MLAB 1982
  • DXYZ N/A
  • Country
  • MLAB United States
  • DXYZ
  • Employees
  • MLAB N/A
  • DXYZ N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • DXYZ
  • Sector
  • MLAB Industrials
  • DXYZ
  • Exchange
  • MLAB Nasdaq
  • DXYZ Nasdaq
  • Market Cap
  • MLAB 341.1M
  • DXYZ 313.1M
  • IPO Year
  • MLAB N/A
  • DXYZ 2024
  • Fundamental
  • Price
  • MLAB $68.98
  • DXYZ $28.02
  • Analyst Decision
  • MLAB Buy
  • DXYZ
  • Analyst Count
  • MLAB 2
  • DXYZ 0
  • Target Price
  • MLAB $113.50
  • DXYZ N/A
  • AVG Volume (30 Days)
  • MLAB 195.2K
  • DXYZ N/A
  • Earning Date
  • MLAB 11-06-2025
  • DXYZ N/A
  • Dividend Yield
  • MLAB 0.89%
  • DXYZ N/A
  • EPS Growth
  • MLAB N/A
  • DXYZ N/A
  • EPS
  • MLAB N/A
  • DXYZ N/A
  • Revenue
  • MLAB $242,351,000.00
  • DXYZ N/A
  • Revenue This Year
  • MLAB $5.38
  • DXYZ N/A
  • Revenue Next Year
  • MLAB $5.25
  • DXYZ N/A
  • P/E Ratio
  • MLAB N/A
  • DXYZ N/A
  • Revenue Growth
  • MLAB 8.33
  • DXYZ N/A
  • 52 Week Low
  • MLAB $55.45
  • DXYZ N/A
  • 52 Week High
  • MLAB $155.12
  • DXYZ N/A
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 48.73
  • DXYZ 52.51
  • Support Level
  • MLAB $63.48
  • DXYZ $28.01
  • Resistance Level
  • MLAB $75.10
  • DXYZ $32.93
  • Average True Range (ATR)
  • MLAB 4.09
  • DXYZ 2.11
  • MACD
  • MLAB 0.81
  • DXYZ 0.63
  • Stochastic Oscillator
  • MLAB 42.97
  • DXYZ 59.87

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About DXYZ Destiny Tech100 Inc. Common Stock

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

Share on Social Networks: